The Changing Face of Pleural Empyemas in Children: Epidemiology and Management




* Department of Pediatrics, Pulmonology Section, Baylor College of Medicine Houston, Texas
Michael E. DeBakey Department of Surgery, Department of Pediatrics, Baylor College of Medicine Houston, Texas
Department of Pediatrics, Nutrition Section, Baylor College of Medicine Houston, Texas
|| Department of Pediatrics, Infectious Diseases Section, Baylor College of Medicine Houston, Texas
Objective. Empyema remains a significant cause of morbidity in children. This study evaluates the changes that have affected the outcome in children with pleural empyema, including the emergence of resistant organisms, the introduction of the pneumococcal conjugate vaccine, and earlier treatment with video-assisted thoracoscopy (VATS).
Methods. A retrospective chart review was performed on all patients who were discharged with a diagnosis of empyema and community-acquired pneumonia over a 10-year period (19932002) at Texas Childrens Hospital in Houston, Texas. Data collected included demographic information, clinical presentation, radiographic studies, laboratory data including culture results, and hospital course.
Results. A total of 230 charts were available for review. The mean age of the patients was 4.0 ± 3.6 years. Of the pleural fluid cultures performed, 32% (69 of 219) were positive. An additional 27 patients had a cause identified by blood culture. The first penicillin-nonsusceptible Streptococcus pneumoniae was identified in 1995, and the first methicillin-resistant Staphylococcus aureus was identified in 1998. After the universal use of the pneumococcal conjugate vaccine, 3 major changes have occurred (19992000 vs 20012002): 1) the number of patients admitted with empyema (per 10 000 admissions) has decreased from 23 to 12.6; 2) the prevalence of S pneumoniae has decreased from 66% (29 of 44) to 27% (4 of 15); and 3) S aureus has become the most common pathogen isolated (18% vs 60%), with 78% of those being methicillin resistant. The use of early VATS (<48 hours after admission) versus late VATS (>48 hours after admission) significantly decreased the length of hospitalization (11.49 ± 6.56 days vs 15.18 ± 8.62 days).
Conclusions. The microbiologic cause of empyema has changed with an increasing incidence of S aureus, particularly methicillin-resistant S aureus. The use of VATS for initial therapy of empyema results in decreased duration of fever and length of hospitalization.
Key Words: empyema community-acquired pneumonia video-assisted thoracic surgery children microbiology
Abbreviations: CTD, chest tube drainage VATS, video-assisted thoracic surgery PCN-NS, penicillin nonsusceptible MIC, minimum inhibitory concentration LOS, length of stay MRSA, methicillin-resistant Staphylococcus aureus PCN-S, penicillin susceptible MSSA, methicillin-susceptible Staphylococcus aureus
Received for publication Aug 18, 2003; Accepted Mar 1, 2004.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
K. Z. Vardakas, D. K. Matthaiou, and M. E. Falagas Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia Eur. Respir. J., November 1, 2009; 34(5): 1148 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Ho, V. C.-C. Cheng, and C.-M. Chu Antibiotic Resistance in Community-Acquired Pneumonia Caused by Streptococcus pneumoniae, Methicillin-Resistant Staphylococcus aureus, and Acinetobacter baumannii Chest, October 1, 2009; 136(4): 1119 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Chen, K.-C. Huang, Y.-C. Chen, H.-H. Hsu, S.-W. Kuo, P.-M. Huang, J.-M. Lee, and Y.-C. Lee Pediatric empyema: Outcome analysis of thoracoscopic management. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1195 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Sawicki, F. L. Lu, C. Valim, R. H. Cleveland, and A. A. Colin Necrotising pneumonia is an increasingly detected complication of pneumonia in children Eur. Respir. J., June 1, 2008; 31(6): 1285 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cohen, M. Weinstein, and D. N. Fisman Cost-effectiveness of Competing Strategies for the Treatment of Pediatric Empyema Pediatrics, May 1, 2008; 121(5): e1250 - e1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. A. de Britto, S. M. M. da Conceicao Silvestre, M. do Carmo Menezes Duarte, and P. G. de Matos Bezerra Clinical profile of pleural empyema and associated factors with prolonged hospitalization in paediatric tertiary centre in Angola, Luanda Trop Doct, April 1, 2008; 38(2): 118 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
C S D Roxburgh, G G Youngson, J A Townend, and S W Turner Trends in pneumonia and empyema in Scottish children in the past 25 years Arch. Dis. Child., April 1, 2008; 93(4): 316 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-T. T. Li and R. L. Gates Primary Operative Management for Pediatric Empyema: Decreases in Hospital Length of Stay and Charges in a National Sample Arch Pediatr Adolesc Med, January 1, 2008; 162(1): 44 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Padman, K. A. King, S. Iqbal, and P. J. Wolfson Parapneumonic Effusion and Empyema in Children: Retrospective Review of the duPont Experience Clinical Pediatrics, July 1, 2007; 46(6): 518 - 522. [Abstract] [PDF] |
||||
![]() |
B. A. Kurt, K. M. Winterhalter, R. H. Connors, B. W. Betz, and J. W. Winters Therapy of Parapneumonic Effusions in Children: Video-Assisted Thoracoscopic Surgery Versus Conventional Thoracostomy Drainage Pediatrics, September 1, 2006; 118(3): e547 - e553. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Rathore, M. Dubik, and L. Barton Rapid Microbial Diagnosis of Empyema AAP Grand Rounds, August 1, 2006; 16(2): 17 - 18. [Full Text] [PDF] |
||||
![]() |
A. L.N. Chapman, J. M. Greig, J. A. Innes, J. C. Hageman, R. Lynfield, S. K. Fridkin, L. G. Miller, F. Perdreau-Remington, and B. Spellberg MRSA in the Community N. Engl. J. Med., August 4, 2005; 353(5): 530 - 532. [Full Text] [PDF] |
||||
![]() |
M. H. Rathore Changing Epidemiology and Management of Empyema AAP Grand Rounds, September 1, 2004; 12(3): 28 - 28. [Full Text] [PDF] |
||||
![]() |
Recent Changes in Pediatric Empyema Journal Watch Infectious Diseases, July 9, 2004; 2004(709): 4 - 4. [Full Text] |
||||















